COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
COVID-19 and solid organ transplantation: a review article
The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …
Early in the outbreak period, transplant societies recommended suspending living kidney …
Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
[HTML][HTML] Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Background Despite concerns that patients with liver transplants might be at increased risk
of adverse outcomes from COVID-19 because of coexisting comorbidities and use of …
of adverse outcomes from COVID-19 because of coexisting comorbidities and use of …
COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature
Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …
[HTML][HTML] Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and
ESCMID published a position paper to provide guidance for physicians involved in the care …
ESCMID published a position paper to provide guidance for physicians involved in the care …
Outcomes of COVID-19 in solid organ transplant recipients: a propensity-matched analysis of a large research network
Background. Organ transplant recipients comprise an immunocompromised and vulnerable
cohort. Outcomes of coronavirus disease 2019 (COVID-19) in solid organ transplant (SOT) …
cohort. Outcomes of coronavirus disease 2019 (COVID-19) in solid organ transplant (SOT) …
Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis
Background Acute kidney injury (AKI) can affect hospitalized patients with coronavirus
disease 2019 (COVID-19), with estimates ranging between 0.5% and 40%. We performed a …
disease 2019 (COVID-19), with estimates ranging between 0.5% and 40%. We performed a …
Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis
Background Immunosuppression and comorbidities increase the risk of severe coronavirus
disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of …
disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of …